Ocular Therapeutix
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $13,475 | $10,785 | $13,250 | $14,544 |
Gross Profit | 11,464 | 9,456 | 11,656 | 12,770 |
EBITDA | -74,120 | -84,552 | -60,575 | -65,344 |
EBIT | -75,971 | -85,835 | -61,822 | -66,416 |
Net Income | -78,763 | -88,612 | -64,654 | -69,418 |
Net Change In Cash | 13,475 | 10,785 | 13,250 | 14,544 |
Free Cash Flow | -70,639 | -70,655 | -57,088 | -56,718 |
Cash | 598,641 | 666,699 | 737,060 | 344,772 |
Basic Shares | 224,952 | 224,099 | 222,921 | 183,919 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $51,823 | $63,723 | $58,443 | $51,494 |
Gross Profit | 45,249 | 58,097 | 53,162 | 46,954 |
EBITDA | -249,781 | -176,143 | -66,415 | -61,907 |
EBIT | -254,104 | -179,929 | -69,398 | -64,016 |
Net Income | -265,939 | -193,506 | -80,736 | -71,038 |
Net Change In Cash | 51,823 | 63,723 | 58,443 | 51,494 |
Cost of Revenue | -61,864 | |||
Free Cash Flow | -216,893 | -135,965 | -76,321 | -63,318 |
Cash | 737,060 | 392,102 | 195,807 | 102,300 |
Basic Shares | 187,241 | 158,265 | 85,596 | 82,644 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.35 |
2026-03-31 | -$0.40 |
2025-12-31 | -$0.29 |
2025-09-30 | -$0.38 |